Silverback Therapeutics, Inc. (NASDAQ:SBTX - Get Free Report) shares shot up 4.9% during mid-day trading on Tuesday . The stock traded as high as $16.59 and last traded at $16.57. 1,408,322 shares traded hands during trading, an increase of 317% from the average session volume of 337,931 shares. The stock had previously closed at $15.80.
Silverback Therapeutics Trading Up 0.7%
The business has a 50-day moving average price of $14.55 and a 200 day moving average price of $13.00. The stock has a market capitalization of $656.26 million, a P/E ratio of -7.52 and a beta of 0.60.
About Silverback Therapeutics
(
Get Free Report)
Silverback Therapeutics, Inc, a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver.
Featured Articles
Before you consider Silverback Therapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silverback Therapeutics wasn't on the list.
While Silverback Therapeutics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
